The anti-proliferative effects of apelin on pulmonary adventitial fibroblasts

L. Brash, C. Church, R. Wadsworth, A. Peacock, D. Welsh (Glasgow, United Kingdom)

Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment
Session: Pulmonary circulation: clinical treatment
Session type: Oral Presentation
Number: 3272
Disease area: Pulmonary vascular diseases

Congress or journal article abstractSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Brash, C. Church, R. Wadsworth, A. Peacock, D. Welsh (Glasgow, United Kingdom). The anti-proliferative effects of apelin on pulmonary adventitial fibroblasts. Eur Respir J 2012; 40: Suppl. 56, 3272

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Anti-fibrotic effect of Atorvastatin on the lung fibroblasts and myofibroblasts
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018

Dexamethasone induces anti-remodelling effects in rat pulmonary arterial smooth muscle cells
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012


Phosphodiesterase-type 3 inhibitor potentiates cAMP generation and antiproliferative effects of treprostinil in pulmonary arterial smooth muscle cells from patients with pulmonary hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010


Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis
Source: Eur Respir J, 58 (6) 2003397; 10.1183/13993003.03397-2020
Year: 2021



The pro-proliferative phenotype of pulmonary microvascular endothelium
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005


In vitro effects of vasodilatory drugs on BMPR2-silenced pulmonary microvascular endothelial cell function
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021


Antifibrosic effects of sulforaphane in human lung fibroblasts from idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - New insights in the treatment of idiopathic pulmonary fibrosis
Year: 2011

The effect of ASK1 inhibition on hypoxia-induced pulmonary artery fibroblast activation and associated paracrine effects on vascular smooth muscle cells
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016

Anti-fibrotic effects of pirfenidone on pulmonary arterial vascular smooth muscle cells
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016

The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin-induced pulmonary fibrosis in rats
Source: Eur Respir J 2002; 20: Suppl. 38, 487s
Year: 2002

Anti-inflammatory effect of bosentan on endothelin-1- and TNF-α-induced GMCSF expression in human airways smooth muscle cells – role of MAPkinases ERK-1,-2
Source: Annual Congress 2007 - Inflammatory cell biology
Year: 2007


Anti-inflammatory and anti-fibrotic effects of sirolimus in bleomycin-induced pulmonary fibrosis in rats
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010

Role of EPAC in transmission of ß-adrenoceptor- and EP2-receptor-induced antiproliferative effects in human pulmonary fibroblasts
Source: Annual Congress 2007 - Recent advances in airway smooth muscle biology
Year: 2007



Antiproliferative effects of drugs affecting different signalling pathways on rat and human pulmonary artery smooth muscle cells
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015

Effect of endothelin-1 and bosentan on gene expressions in the cultured pulmonary artery smooth muscle cells
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010

Esterification of iloprost enhances its protective effects on pulmonary endothelium
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020



NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009

Inhibition of HGF secretion by pulmonary fibroblasts from IPF: involvement of PGE2
Source: Eur Respir J 2003; 22: Suppl. 45, 8s
Year: 2003

VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009

Different effects of mesenchymal stem cells on elastase-induced pulmonary emphysema and macrophages activity in rats
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011